Oscar Health (NYSE:OSCR) Now Covered by Analysts at Jefferies Financial Group

Jefferies Financial Group started coverage on shares of Oscar Health (NYSE:OSCR) in a report published on Tuesday morning, MarketBeat Ratings reports. The firm issued an underperform rating and a $12.00 price target on the stock.

OSCR has been the subject of a number of other research reports. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.56.

Oscar Health Trading Down 5.0 %

OSCR opened at $13.64 on Tuesday. The stock has a market capitalization of $3.37 billion, a P/E ratio of -227.33 and a beta of 1.64. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 12 month low of $7.67 and a 12 month high of $23.79. The firm’s fifty day simple moving average is $16.46 and its 200 day simple moving average is $17.68.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.29) earnings per share. As a group, research analysts anticipate that Oscar Health will post -0.01 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the sale, the director now owns 89,512 shares of the company’s stock, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Steven Wolin sold 19,580 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the sale, the chief operating officer now owns 102,598 shares of the company’s stock, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Neo Ivy Capital Management acquired a new position in shares of Oscar Health during the 3rd quarter worth approximately $600,000. Geode Capital Management LLC increased its stake in Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock worth $92,062,000 after acquiring an additional 455,205 shares during the period. Barclays PLC raised its holdings in Oscar Health by 217.5% in the 3rd quarter. Barclays PLC now owns 325,818 shares of the company’s stock valued at $6,911,000 after acquiring an additional 223,189 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Oscar Health during the 3rd quarter valued at $2,764,000. Finally, Soros Fund Management LLC acquired a new stake in shares of Oscar Health during the 3rd quarter worth $12,726,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.